Abstract: A new non-HIV vaccine antigen from Mycoplasma sp. permease capable of inducing a mucosal neutralizing protective antibody response against HIV infection, a neutralizing antibody directed to said antigen, and a method for the identification of new antigens from the mucosal microbiota for the development of vaccines against pathogens.
Type:
Grant
Filed:
February 5, 2015
Date of Patent:
April 30, 2019
Assignee:
B Cell Design SAS
Inventors:
Raphaëlle Claude El Habib, Régis Sodoyer, Armelle Cuvillier, Christiane Moog